Kim Pedersen

1.3k total citations
14 papers, 992 citations indexed

About

Kim Pedersen is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Kim Pedersen has authored 14 papers receiving a total of 992 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 9 papers in Radiology, Nuclear Medicine and Imaging and 6 papers in Molecular Biology. Recurrent topics in Kim Pedersen's work include Monoclonal and Polyclonal Antibodies Research (9 papers), HER2/EGFR in Cancer Research (8 papers) and Cell Adhesion Molecules Research (5 papers). Kim Pedersen is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (9 papers), HER2/EGFR in Cancer Research (8 papers) and Cell Adhesion Molecules Research (5 papers). Kim Pedersen collaborates with scholars based in Spain, Palestinian Territory and United States. Kim Pedersen's co-authors include Joaquı́n Arribas, Josep Lluís Parra-Palau, José Baselga, Maurizio Scaltriti, Santiago Ramón y Cajal, José Baselga, José Jiménez, Josep-Lluís Parra, Marta Guzmán and Chandra Verma and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Molecular and Cellular Biology.

In The Last Decade

Kim Pedersen

14 papers receiving 971 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kim Pedersen Spain	12	761	449	351	139	113	14	992
Christel Larbouret France	18	652 0.9×	356 0.8×	366 1.0×	115 0.8×	224 2.0×	36	971
Sara Kenkare-Mitra United States	4	1.0k 1.3×	847 1.9×	426 1.2×	55 0.4×	111 1.0×	5	1.3k
Monica M. Reinholz United States	20	936 1.2×	372 0.8×	506 1.4×	422 3.0×	91 0.8×	38	1.3k
Josep Lluís Parra-Palau Spain	9	389 0.5×	264 0.6×	239 0.7×	77 0.6×	61 0.5×	14	570
Josep-Lluís Parra Spain	6	553 0.7×	255 0.6×	627 1.8×	134 1.0×	62 0.5×	7	1.0k
Natalia Sergina United States	9	866 1.1×	489 1.1×	681 1.9×	113 0.8×	70 0.6×	9	1.3k
Thinh Q. Pham United States	8	913 1.2×	411 0.9×	629 1.8×	183 1.3×	82 0.7×	10	1.3k
Michael V. Grandal Denmark	12	365 0.5×	180 0.4×	564 1.6×	57 0.4×	122 1.1×	13	897
Hong-Mei Rong United States	5	852 1.1×	525 1.2×	536 1.5×	285 2.1×	32 0.3×	8	1.2k
Dhara N. Amin United States	12	684 0.9×	284 0.6×	782 2.2×	334 2.4×	100 0.9×	19	1.2k

Countries citing papers authored by Kim Pedersen

Since Specialization

Citations

This map shows the geographic impact of Kim Pedersen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kim Pedersen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kim Pedersen more than expected).

Fields of papers citing papers by Kim Pedersen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kim Pedersen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kim Pedersen. The network helps show where Kim Pedersen may publish in the future.

Co-authorship network of co-authors of Kim Pedersen

This figure shows the co-authorship network connecting the top 25 collaborators of Kim Pedersen. A scholar is included among the top collaborators of Kim Pedersen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kim Pedersen. Kim Pedersen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Arenas, Enrique J., Kim Pedersen, Behnam Nabet, et al.. (2021). The Transcription Factor SLUG Uncouples Pancreatic Cancer Progression from the RAF–MEK1/2–ERK1/2 Pathway. Cancer Research. 81(14). 3849–3861. 14 indexed citations

He, Yi, Tina Manon‐Jensen, Lars Arendt‐Nielsen, et al.. (2018). A biomarker of hypertrophic chondrocytes, type X collagen, completely distinguishes between OA and RA. Osteoarthritis and Cartilage. 26. S175–S176. 1 indexed citations

Pedersen, Kim, Cristina Bernadó Morales, Teresa Macarulla, et al.. (2017). Pancreatic cancer heterogeneity and response to Mek inhibition. Oncogene. 36(40). 5639–5647. 18 indexed citations

Massó-Vallés, Daniel, Toni Jauset, Erika Serrano, et al.. (2015). Ibrutinib Exerts Potent Antifibrotic and Antitumor Activities in Mouse Models of Pancreatic Adenocarcinoma. Cancer Research. 75(8). 1675–1681. 92 indexed citations

Parra-Palau, Josep Lluís, Beatriz Morancho, Vicente Peg, et al.. (2014). Effect of p95HER2/611CTF on the Response to Trastuzumab and Chemotherapy. JNCI Journal of the National Cancer Institute. 106(11). 42 indexed citations

Fluck, Mariano F. Zacarías, Kim Pedersen, Josep Lluís Parra-Palau, et al.. (2013). Constitutive HER2 Signaling Promotes Breast Cancer Metastasis through Cellular Senescence. Cancer Research. 73(1). 450–458. 77 indexed citations

Pedersen, Kim, Françesc Canals, Aleix Prat, Josep Tabernero, & Joaquı́n Arribas. (2013). PELO negatively regulates HER receptor signalling and metastasis. Oncogene. 33(9). 1190–1197. 13 indexed citations

Arribas, Joaquı́n, José Baselga, Kim Pedersen, & Josep Lluís Parra-Palau. (2011). p95HER2 and Breast Cancer. Cancer Research. 71(5). 1515–1519. 171 indexed citations

Arribas, Joaquı́n, Josep Lluís Parra-Palau, & Kim Pedersen. (2010). HER2 Fragmentation and Breast Cancer Stratification. Clinical Cancer Research. 16(16). 4071–4073. 12 indexed citations

10.

Parra-Palau, Josep Lluís, Kim Pedersen, Vicente Peg, et al.. (2010). A Major Role of p95/611-CTF, a Carboxy-Terminal Fragment of HER2, in the Down-modulation of the Estrogen Receptor in HER2-Positive Breast Cancers. Cancer Research. 70(21). 8537–8546. 45 indexed citations

11.

Pedersen, Kim, Sirle Laos, Anna Bach-Faig, et al.. (2009). A Naturally Occurring HER2 Carboxy-Terminal Fragment Promotes Mammary Tumor Growth and Metastasis. Molecular and Cellular Biology. 29(12). 3319–3331. 137 indexed citations

12.

Garcı́a-Castillo, Jesús, Kim Pedersen, Joan Josep Bech‐Serra, et al.. (2009). HER2 Carboxyl-terminal Fragments Regulate Cell Migration and Cortactin Phosphorylation. Journal of Biological Chemistry. 284(37). 25302–25313. 27 indexed citations

13.

Scaltriti, Maurizio, Chandra Verma, Marta Guzmán, et al.. (2008). Lapatinib, a HER2 tyrosine kinase inhibitor, induces stabilization and accumulation of HER2 and potentiates trastuzumab-dependent cell cytotoxicity. Oncogene. 28(6). 803–814. 342 indexed citations

14.

Scaltriti, Maurizio, Chandra Verma, Marta Guzmán, et al.. (2008). Effect of lapatinib on accumulation of inactive HER2 at the cell membrane and on antibody-dependent cellular cytotoxicity (ADCC) mediated by trastuzumab: A novel mechanism for the enhanced effects of combined anti-HER2 therapy. Journal of Clinical Oncology. 26(15_suppl). 3594–3594. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact